LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab ...

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...

Arcutis Biotherapeutics said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its Zoryve topical treatment for infants with atopic dermatitis, the most ...

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-l ...

Eli Lilly Canada Inc. (Lilly Canada) has officially received a long-awaited positive recommendation (reimbursement with conditions) from Canada's Drug Agency (CDA-AMC) for its medicine, Ebglyss®, for ...

In the INTEGUMENT-INFANT trial, 34.4% of patients achieved vIGA-AD success and 58.3% reached EASI-75 at week 4.

Monsoon humidity can turn your scalp into a breeding ground for dandruff-causing fungus. Dermatologists explain why flakes ...

A pet's skin and coat are among the clearest indicators of its overall health. Just as in humans, the skin is often the first ...

These are the blooms to watch out for if you have kids or pets.

Regardless of your hair washing schedule or whether you prefer wash-out masks or leave-in oils, there are lots of scalp ...

I had a bad reaction to the barbs of a prickly pear cactus. Most of the itching stopped after I found and removed 20 tiny ...

Dupixent (dupilumab) is one of the most widely prescribed biologic medications in the United States. Doctors use it to treat ...